KCNJ6 and Down syndrome: Conversely, GIRK2 over-expression in transgenic models of Down syndrome leads to reduced LTP (Kleschevnikov et al., 2004; Siarey et al., 2005), but enhanced LTD (Siarey et al., 2005; Cooper et al., 2012).